City

Beijing (1)

Chengdu (1)

Shanghai (1)

Xi'an (1)

Zhengzhou (1)

Zurich (1)

Condition

Neoplasm of Bone (2)

Neoplasms (1)

Sarcoma (1)

Sarcoma of Bone (1)

Soft Tissue Neoplasm (1)

Soft Tissue Sarcoma (1)

Overall Status

Terminated (1)

Unknown status (1)

Phase

phase 2 (1)

Sponsor

Balgrist University Hospital (1)

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)

Collaborator

University of Bern (1)

Intervention

anlotinib (1)

registration (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

neoplasm of bone

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Tumor of Bone Trial in China (Anlotinib)

Unknown status

Neoplasm of Bone

Anlotinib

Beijing, Beijing, China
+5 more

May 20, 2019

Sarcoma, Tumor of Bone, Tumors Trial in Zurich (Registration)

Terminated

Sarcoma
+5 more

Registration

Zurich, Switzerland

Balgrist University Hospital

Sep 30, 2018